Atlas Trials

Surufatinib Combined With Toripalimab and HAIC in the Treatment of Inoperable or Metastatic Intrahepatic Cholangiocarcinoma

Clinical trial NCT06313554 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06313554
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Intrahepatic Cholangiocarcinoma
Start date
2024-05-20
Primary completion
2024-05-20
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.